IP Library Assignment 020666/0224
Patent Assignment
Reel/Frame 020666/0224

Assignment of Assignor's Interest

Recorded: 2008-03-18 Pages: 9
Assignor
CELL GENESYS, INC.
Executed: 2007-12-21
Assignee
GBP IP, LLC
537 STEAMBOAT ROAD, SUITE 200, GREENWICH, CONNECTICUT, 06830
Covered Properties (21)
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent: 5,834,256 →
Application: 08/076,299 →
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent: 5,686,279 →
Application: 08/258,152 →
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent: 5,858,740 →
Application: 08/438,582 →
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent: 6,051,427 →
Application: 08/517,488 →
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent: 5,994,136 →
Application: 08/989,394 →
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent: 6,218,187 →
Application: 09/266,596 →
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent: 6,165,782 →
Application: 09/271,365 →
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent: 6,428,953 →
Application: 09/604,013 →
Selection System for Generating Efficient Packaging Cells for Lentiviral Vectors
Patent: 6,797,512 →
Application: 09/831,623 →
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent: 6,506,604 →
Application: 09/944,411 →
Publication: US 2002/0106799
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent: 7,250,299 →
Application: 10/031,639 →
Lentiviral Vectors Encoding Clotting Factors for Gene Therapy
Patent: 6,808,905 →
Application: 10/145,289 →
Publication: US 2003/0077812
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent: 6,924,144 →
Application: 10/192,085 →
Publication: US 2002/0173030
Method for Production of High Titer Virus and High Efficiency Retroviral Mediated Transduction of Mammalian Cells
Patent: 7,252,991 →
Application: 10/260,516 →
Publication: US 2003/0199093
Lentiviral Vector Particles Resistant to Complement Inactivation
Patent: 6,790,641 →
Application: 10/425,323 →
Publication: US 2003/0207445
Pseudotyped Retroviral Vectors
Patent: 6,863,884 →
Application: 10/425,324 →
Publication: US 2003/0207438
Liver Specific Transcriptional Enhancer
Patent: 7,179,903 →
Application: 10/885,457 →
Publication: US 2004/0259208
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent: 7,083,981 →
Application: 11/186,497 →
Publication: US 2005/0255597
Method and Means for Producing High Titer, Safe Recombinant Lentivirus Vectors
Patent: 8,846,385 →
Application: 11/460,136 →
Publication: US 2008/0286836
Lentiviral Vectors Featuring Liver Specific Transcriptional Enhancer and Methods of Using Same
Patent: 7,745,179 →
Application: 11/626,192 →
Publication: US 2007/0178592
Method and Means for Producing High Titer, Safe, Recombinant Lentivirus Vectors
Patent: 8,652,837 →
Application: 11/781,094 →
Publication: US 2008/0241929
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 12, 2001
From: MCGUINNESS, RYAN; NALDINI, LUIGI
To: CELL GENESYS, INC.
Reel/Frame 012182/0636 →
Assignment of Assignor's Interest Aug 19, 2002
From: MCARTHUR, JAMES G.; TALBOT, DALE JOHN; SIMMONS, ANDREW D.; MCGUINESS, RYAN
To: CELL GENESYS, INC.
Reel/Frame 013214/0493 →
Corrective Assignment to Correct the Execution Date of the 4TH Assignor. Document Previously Recorded at Reel 013214 Frame 0493. Nov 19, 2002
From: MCARTHUR, JAMES G.; TALBOT, DALE JOHN; SIMMONS, ANDREW D.; MCGUINNESS, RYAN
To: CELL GENESYS, INC.
Reel/Frame 013507/0238 →
Assignment of Assignor's Interest Aug 22, 2006
From: NALDINI, LUIGI; DULL, THOMAS; FARSON, DEBORAH A.; WITT, ROCHELLE
To: CELL GENESYS, INC.
Reel/Frame 018154/0267 →
Assignment of Assignor's Interest Oct 24, 2006
From: MCARTHUR, JAMES G.; TALBOT, DALE JOHN; SIMMONS, ANDREW D.; MCGUINNESS, RYAN
To: CELL GENESYS, INC.
Reel/Frame 018429/0238 →
Assignment of Assignor's Interest Jan 25, 2007
From: MCARTHUR, JAMES G.; TALBOT, DALE JOHN; SIMMONS, ANDREW D.; MCGUINNESS, RYAN
To: CELL GENESYS, INC.
Reel/Frame 018807/0125 →
Assignment of Assignor's Interest Sep 4, 2014
From: GBP IP, LLC
To: MILTENYI BIOTEC TECHNOLOGY, INC
Reel/Frame 033666/0185 →
Assignment of Assignor's Interest Mar 23, 2016
From: GBP IP, LLC
To: MILTENYI BIOTEC TECHNOLOGY, INC.
Reel/Frame 038078/0807 →
Assignment of Assignor's Interest Feb 26, 2018
From: MILTENYI BIOTEC TECHNOLOGY, INC.
To: MILTENYI BIOTEC GMBH
Reel/Frame 045035/0212 →
Assignment of Assignor's Interest Dec 29, 2019
From: MILTENYI BIOTEC GMBH
To: MILTENYI BIOTEC B.V. & CO. KG
Reel/Frame 051443/0669 →